Global Community

Thesis ASML operates as an absolute monopoly at the most critical bottleneck of the global semiconductor supply chain: Extreme Ultraviolet (EUV) lithography. Without ASML's multi-million-dollar machines, the manufacturing of cutting-edge logic and memory chips—which are foundational to the global AI build-out, high-performance computing, and advanced consumer electronics—is physically impossible.Read more

Strengths ​Proprietary hardware advantage: Custom ASICs provide a distinct cost-to-performance moat that is exceptionally difficult for software-only competitors to replicate. ​Unified architecture: A single operating system (FortiOS) across all environments reduces complexity for customers and drives strong ecosystem lock-in.Read more

Vistra looks like a quiet backbone behind the boom in data centers, with long-term power deals tied to household-name tech companies. The catch is that regulators, shifting tech spending, and power-market surprises could quickly change how safe those deals and returns really are.Read more

Zevra Therapeutics is at the most profitable inflection point in biotechnology: the transition from cash-burning R&D to cash-generating commercial sales. With the recent FDA approval of Miplyffa (for Niemann-Pick disease type C), Zevra has secured the first and only approved treatment for this ultra-rare condition.Read more

Zoetis sells medicines and vaccines for pets and farm animals, and long-term demand keeps rising as people treat pets more like family and as more households buy more meat and dairy. Recent worries around a key pet treatment have weighed on sentiment, but the business still looks hard to copy and built to keep growing—if those concerns don’t deepen.Read more

Nokia rides rising demand for AI and cloud gear, and it pushes into defense with AI tools for modern mobile networks. A strong recent quarter and a sturdy cash cushion add confidence, but the shares have already run up and can pull back when investors take profits.Read more

DuChemBio already supplies most of South Korea’s Alzheimer’s PET scans, and a big push to build out nuclear medicine treatment capacity could pull the company into a much larger role. The catch is that these projects take time to show up in results, so the key question is whether delays, hospital buildouts, or isotope supply issues derail the upside.Read more

Samsara sells tracking and camera tools for truck fleets, but many drivers see them as constant surveillance and may push back hard. The big bet is that regulators or fleet owners make this tech standard anyway, even if adoption is bumpy.Read more

ServiceNow looks dull on the surface, but many large companies rely on it to keep everyday work moving across IT, HR, security, and customer support. The bigger story is its push to help companies keep control of how artificial intelligence is used inside the business, even when the stock falls out of favor.Read more